Literature DB >> 2173789

Thermally inactivated simian virus 40 tsA58 mutant T antigen cannot initiate viral DNA replication in vitro.

I Reynisdóttir1, D R O'Reilly, L K Miller, C Prives.   

Abstract

The mutation in the temperature-sensitive tsA58 mutant T antigen (Ala-438----Val) lies within the presumptive ATP-binding fold. We have constructed a recombinant baculovirus that expresses large quantities of the tsA58 T antigen in infected insect cells. The mutant T antigen mediated simian virus 40 origin-containing DNA (ori-DNA) synthesis in vitro to nearly the same extent as similar quantities of wild-type T antigen at 33 degrees C. However, if wild-type and tsA58 T antigens were heated at 41 degrees C in replication extracts prior to addition of template DNA, the tsA58 T antigen but not the wild type was completely inactivated. The mutant protein displayed greater thermosensitivity for many of the DNA replication activities of T antigen than did the wild-type protein. Some of the replication functions of tsA58 T antigen were differentially affected depending on the presence or absence of ATP during the preheating period. When tsA58 T antigen was preheated in the presence of ATP at 41 degrees C for a time sufficient to completely inactivate its ability to replicate ori-DNA in vitro, it displayed substantial ATPase and normal DNA helicase activities. Conversely, when preheated in the absence of nucleotide, it completely lost both ATPase and helicase activities. Preheating tsA58 T antigen, even in the presence of ATP, led to drastic reductions in its ability to bind to and unwind DNA containing the replication origin. The mutant T antigen also displayed thermosensitivity for binding to and unwinding nonspecific double-stranded DNA in the presence of ATP. Our results suggest that the interactions of T antigen with ATP that are involved in T-antigen DNA binding and DNA helicase activities are different. Moreover, we conclude, consistent with its phenotype in vivo, that the tsA58 T antigen is defective in the initiation but not in the putative elongation functions of T antigen in vitro.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2173789      PMCID: PMC248798          DOI: 10.1128/JVI.64.12.6234-6245.1990

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  75 in total

1.  The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen.

Authors:  E H Wang; P N Friedman; C Prives
Journal:  Cell       Date:  1989-05-05       Impact factor: 41.582

Review 2.  Baculoviruses as gene expression vectors.

Authors:  L K Miller
Journal:  Annu Rev Microbiol       Date:  1988       Impact factor: 15.500

Review 3.  A model for initiation at origins of DNA replication.

Authors:  D Bramhill; A Kornberg
Journal:  Cell       Date:  1988-09-23       Impact factor: 41.582

4.  Temperature-sensitive mutants identify crucial structural regions of simian virus 40 large T antigen.

Authors:  G Loeber; M J Tevethia; J F Schwedes; P Tegtmeyer
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

5.  Sequence independent duplex DNA opening reaction catalysed by SV40 large tumor antigen.

Authors:  M Scheffner; R Wessel; H Stahl
Journal:  Nucleic Acids Res       Date:  1989-01-11       Impact factor: 16.971

6.  Helicase, DNA-binding, and immunological properties of replication-defective simian virus 40 mutant T antigens.

Authors:  K Auborn; M Guo; C Prives
Journal:  J Virol       Date:  1989-02       Impact factor: 5.103

7.  The zinc finger region of simian virus 40 large T antigen.

Authors:  G Loeber; R Parsons; P Tegtmeyer
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

8.  Purification of replication protein C, a cellular protein involved in the initial stages of simian virus 40 DNA replication in vitro.

Authors:  D M Virshup; T J Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1989-05       Impact factor: 11.205

9.  Simian virus 40 (SV40) large tumor antigen causes stepwise changes in SV40 origin structure during initiation of DNA replication.

Authors:  J M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

10.  Localized melting and structural changes in the SV40 origin of replication induced by T-antigen.

Authors:  J A Borowiec; J Hurwitz
Journal:  EMBO J       Date:  1988-10       Impact factor: 11.598

View more
  7 in total

1.  Functional characterization of temperature-sensitive mutants of simian virus 40 large T antigen.

Authors:  S Ray; M E Anderson; G Loeber; D McVey; P Tegtmeyer
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

2.  trans-Dominant and non-trans-dominant mutant simian virus 40 large T antigens show distinct responses to ATP.

Authors:  A M Castellino; P Cantalupo; I M Marks; J V Vartikar; K W Peden; J M Pipas
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  Murine polyomavirus and simian virus 40 large T antigens produce different structural alterations in viral origin DNA.

Authors:  S Bhattacharyya; H E Lorimer; C Prives
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

4.  Two conditional tsA mutant simian virus 40 T antigens display marked differences in thermal inactivation.

Authors:  I Reynisdóttir; C Prives
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

5.  p53-dependent growth arrest of REF52 cells containing newly amplified DNA.

Authors:  Y Ishizaka; M V Chernov; C M Burns; G R Stark
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-11       Impact factor: 11.205

6.  In vivo and in vitro analyses of recombinant baculoviruses lacking a functional cg30 gene.

Authors:  A L Passarelli; L K Miller
Journal:  J Virol       Date:  1994-02       Impact factor: 5.103

7.  Review of the history and current status of cell-transplant approaches for the management of neuropathic pain.

Authors:  Mary J Eaton; Yerko Berrocal; Stacey Q Wolfe; Eva Widerström-Noga
Journal:  Pain Res Treat       Date:  2012-06-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.